Auron Therapeutics, Inc.

Auron Therapeutics, Inc. company information, Employees & Contact Information

Updated June 2026

Quick answer

Auron Therapeutics, Inc. is a Biotechnology company. It has approximately 25 employees on record. Contact data was last refreshed in June 2026. Find Auron Therapeutics, Inc.'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

Auron Therapeutics is a privately held patient-centered, platform-powered, product-driven oncology company. We are the leaders in identifying and targeting cell state to treat a range of solid tumors and hematological malignancies.
Looking for a particular Auron Therapeutics, Inc. employee's phone or email?

Auron Therapeutics, Inc. Questions

News

Auron Therapeutics Expands Leadership with Appointment of Glenn Goddard as Chief Financial Officer - GlobeNewswire

Auron Therapeutics Expands Leadership with Appointment of Glenn Goddard as Chief Financial Officer GlobeNewswire

Auron Announces Oral Presentation on Preclinical Data from Proprietary AURIGIN™ Platform at the AI in Biomedicine Keystone Symposia - Yahoo Finance

Auron Announces Oral Presentation on Preclinical Data from Proprietary AURIGIN™ Platform at the AI in Biomedicine Keystone Symposia Yahoo Finance

AUTX-703 Receives FDA Fast Track Designation in Relapsed/Refractory AML - OncLive

AUTX-703 Receives FDA Fast Track Designation in Relapsed/Refractory AML OncLive

Auron Therapeutics to Participate in the 8th Annual Targeted Protein Degradation & Induced Proximity Summit - GlobeNewswire

Auron Therapeutics to Participate in the 8th Annual Targeted Protein Degradation & Induced Proximity Summit GlobeNewswire

Auron Therapeutics announces $48 million Series A financing to drive novel oncology pipeline leveraging a machine learning, multi-omics-based platform - Yahoo Finance

Auron Therapeutics announces $48 million Series A financing to drive novel oncology pipeline leveraging a machine learning, multi-omics-based platform Yahoo Finance

Auron Therapeutics Announces FDA Clearance to Initiate - GlobeNewswire

Auron Therapeutics Announces FDA Clearance to Initiate GlobeNewswire

Auron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic Malignancies - GlobeNewswire

Auron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic Malignancies GlobeNewswire

Top Auron Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant